Low-dose oral prolonged-release oxycodone/naloxone for chronic pain in elderly patients with cognitive impairment: an efficacy–tolerability pilot study

OBJECTIVE: This pilot study evaluated the efficacy and safety of prolonged-release oxycodone/naloxone (OXN-PR) in older subjects with chronic pain and mild-to-moderate cognitive impairment. METHODS: This was a prospective, observational, open-label study of 45-day duration. Patients with moderate-to...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Neuropsychiatr Dis Treat
Auteurs principaux: Petrò, Emiliano, Ruffini, Elena, Cappuccio, Melania, Guerini, Valeria, Belotti, Gloria, Fascendini, Sara, Licini, Cristina, Marcassa, Claudio
Format: Artigo
Langue:Inglês
Publié: Dove Medical Press 2016
Sujets:
Clinical Trial Report
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4780665/
https://ncbi.nlm.nih.gov/pubmed/27042069
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S98511
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires